Figure 3.

Cardiac function assessment in rats with cardiorenal HFpEF and effects of chronic treatment with Telmisartan on cardiorenal HFpEF phenotype. The mean ± SD of systolic blood pressure (a), diastolic blood pressure (b), and BNP (c) at Baseline and at week 16 after the surgery. The E/A ratio in echocardiography at week 16 (d) and the quantified mean ± SD of E/A ratio (e), and ejection fraction (f) at Baseline and at week 16 after the surgery. BNP indicates brain natriuretic peptide; E/A: early to late diastolic transmitral flow velocity. (A color version of this figure is available in the online journal.)